Maya Jerath, MD
Allergy & Immunology · Saint Louis, MONPI 1467661801
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,438 of the $9,390 with a category attached, or 68.6%. Novartis accounts for 81.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $8,383 and has fallen 93.6% since, to $536 in 2025.
Across 31 payments — averaging $302.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$8K
- AstraZeneca$928
- BD$413
- CSL Behring$186
- Regeneron Healthcare Solutions, Inc.$95
- Sanofi$69
- plus $90 from 3 others
Across 4 payments — averaging $29,989 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$83K
- Novartis$36K
What the payments were for
- Consulting fees$6,43869%
- Travel & lodging$1,25513%
- Food & beverage$1,60217%
- Education$951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 13 | $7,610 |
| AstraZeneca | 6 | $928 |
| BD | 1 | $413 |
| CSL Behring | 3 | $186 |
| Regeneron Healthcare Solutions, Inc. | 1 | $95 |
| Sanofi | 2 | $69 |
| Pfizer | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Optinose US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,390 in reported general payments places this provider in the 70th percentile of 61 allergy & immunology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 24 | $89,615 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 17 | $46,932 |
| Cromolyn Sodium | 37 | $13,353 |
| DuleraMometasone/Formoterol | 19 | $6,290 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 26 | $4,503 |
| Epinephrine | 24 | $3,134 |
| Azelastine Hcl | 74 | $2,119 |
| Hydroxychloroquine Sulfate | 55 | $1,061 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $836 |
| Ipratropium Bromide | 32 | $817 |
| Montelukast Sodium | 53 | $416 |
| Famotidine | 19 | $330 |
| Fluticasone Propionate | 37 | $311 |
| Hydroxyzine Hcl | 19 | $292 |
| Sodium Chloride0.9 % Sodium Chloride | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Saint Louis
- H James WednerSaint Louis$420K
- Manoj WarrierSaint Louis$316K
- Jeffrey TillinghastSaint Louis$278K
- Aaron Ver HeulSaint Louis$28K
- Peggy KendallSaint Louis$20K
- Michael BortsSaint Louis$17K
- Jeremy KatcherSaint Louis$16K
- Elyra FigueroaSaint Louis$11K
- Barbara JostSaint Louis$9K
- Cheshil DixitSaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.